Cipla receives final approval for its ANDA
(UNI) Cipla Limited on Monday announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Medroxyprogesterone Injectable, 150mg/mL from the United States Food and Drug …
Cipla receives final approval for its ANDA Read More